ArticleFrontiers in immunology2022

Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report.

Cui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.